SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEK 490,20
arrow_upward
+0,45%(+2,20) 1D
30 Okt., 17:00:00 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
SEK 488,00
High
SEK 491,00
Low
SEK 485,40
Mkt. cap
175,31 mjd
Avg. vol.
335,45 k
Volume
157,56 k
P/E ratio
26,04
52-wk high
SEK 492,00
52-wk low
SEK 314,40
EPS
SEK 18,83
Shares outstanding
357,64 m
No. of employees
2 k
Open
SEK 488,00
High
SEK 491,00
Low
SEK 485,40
Mkt. cap
175,31 mjd
Avg. vol.
335,45 k
Volume
157,56 k
P/E ratio
26,04
52-wk high
SEK 492,00
52-wk low
SEK 314,40
EPS
SEK 18,83
Shares outstanding
357,64 m
No. of employees
2 k
News stories
From web sources and news partners
The Motley Fool
·
15 minute gelede
A Wall Street Firm Modeled Out an AI Crash: S&P 500 Down 30%, $20 Trillion Gone. But Here's What Happens Next
Yahoo Finance
·
30 minute gelede
ASML (NasdaqGS:ASML) Stock Looks Fairly Valued On Its 149% Run
Seeking Alpha
·
50 minute gelede
Morgan Stanley's Wilson sees 9% S&P 500 drop before rally to 8,000
CNBC
·
1 dag gelede
Anthropic's path to the Nasdaq just got a lot bumpier
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)